Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants
Frey, S. E., Peiperl, L., McElrath, M. J., Kalams, S., Goepfert, P. A., Keefer, M. C., Baden, L. R., Lally, M. A., Mayer, K., Blattner, W. A., Harro, C. D., Hammer, S. M., Gorse, G. J., Hural, J., TomVolume:
21
Langue:
english
Journal:
Clinical and Vaccine Immunology
DOI:
10.1128/CVI.00450-14
Date:
November, 2014
Fichier:
PDF, 1.48 MB
english, 2014